Skip to content
All Updates
- 59. Rapid Alert: Spurious/Falsified Drug Product i.e. Sandostatin LAR 20mg injection (Batch # 380531)November 17, 2026
- DRAP Launches Online Licensing and Registration System for Alternative Medicines and Health ProductsNovember 17, 2026
- 58. Rapid Alert: Spurious/Adulterated Gabica Capsule 300mgNovember 17, 2026
- S.R.O 2118(I)/2026 Fee for Alternative Medicines and Health Products (16.11.2026)November 17, 2026
- S.R.O.2117(I)/2026 (Alternative Medicines and Health Products Rules, 2026 (16.11.2026))November 17, 2026
- 57. Recall Alert: Drug product Declared as Substandard by Central Drugs Laboratories (CDL) KarachiNovember 16, 2026
- 56. Recall Alert: Drug products declared Substandard/Misbranded by Drug Testing laboratories PunjabNovember 16, 2026
- 55. Rapid Alert: Drug products declared Substandard/Adulterated by Drug Testing laboratories PunjabNovember 16, 2026
- Mandatory Compliance,Data Accuracy,System Verification for 2D barcoding and Serialization Requirments.November 16, 2026
- 54. Recall Alert: Drug products declared Substandard by Drug Testing laboratories PunjabNovember 16, 2026
- 53. Rapid Alert: Spurious/Falsified Hexaxim Vaccine (Batch # X3H421VA)November 12, 2026
- 52. Rapid Alert: Spurious/Falsified Axtin Soft Gels (Batch # AXAF2301)November 12, 2026
- Draft Therapeutic Goods (Federal Inspectors, Federal Government Analysts and Federal Quality Control Laboratories) Rules, 2026 (11.11.2026)November 11, 2026
- Conducting a Study to Assess the Impact of De-Regulation of Prices of Drugs on Pharmaceutical SectorNovember 8, 2026
- 50. Rapid Alert: Adulterated/Substandard/Spurious/Unregistered Drug ProductsNovember 5, 2026
- 51. Rapid Alert: Drug Products Declared as “Unregistered” by Central Drugs Laboratory, KarachiNovember 5, 2026
- Clarification Regarding 1688(I)/2026 dated 6,Oct 2026November 5, 2026
- Directive Regarding Mandatory Printing of Disclaimer on the Labels of Formula Milk Products Intended for Infants and Young Children Aged 1 to 36 MonthsNovember 5, 2026
- Guideline for Lot Release of Human Vaccines, Blood Products (Plasma Derivatives Medicinal Products) and Anti-Sera.November 4, 2026
- 49. Rapid Alert: SPURIOUS/FALSIFIED RHOPHYLAC 300 INJECITION (BATCH NUMBER P100830101)November 2, 2026
- Career Opportunities(Balochitan Quota)November 2, 2026
- 48. Rapid Alert: Spurious/Falsified INFLUVAC TETRA VACCINE (BATCH # P13)October 30, 2026
- Guidelines on Establishment of Pharmaceutical Unit, Grant And Renewal of Drug Manufacturing License thereofOctober 30, 2026
- S.R.O. 1915(I)/2026, Notification of Amendments in the Drugs (Research) Rules 1978 (28.10.2026)October 29, 2026
- 47. Rapid Alert: Falsified INFLUENZA VACCINE VAXIGRIP TETRA (BATCH # Y4B34)October 27, 2026
- 46. Recall Alert: Substandard Cikina Umblical Cord ClampOctober 27, 2026
- 45. Recall Alert (Carapamin Injection & Librax Tablet/Dragees)October 23, 2026
- 44. Rapid Alert: Spurious/Falsified BREXIN TABLETOctober 22, 2026
- 43. Rapid Alert: Spurious/Falsified (Velosef 500mg tablet, Augmentin 625mg tablet, No-Spa Forte 80mg tablet, Mucaine Suspension)October 21, 2026
- Invitation to Bid (Provision of Housekeeping, Janitorial and Support staff for DRAP Offices)October 21, 2026
- 42. Recall Alert: SUBSTANDARD & MISBRANDED CLINIC DISPOSABLE SYRINGES 20ML BY M/S SURGI PLAST, GADOON AMAZAI, KPKOctober 20, 2026
- 41. Recall Alert: WFI (Batch # W-174), M/s City Pharmaceutical Laboratories (DML#00723)October 19, 2026
- 40. Rapid Alert: Spurious/Falsified Nasomet Aqueous Nasal Spray, Batch No. FW-099October 19, 2026
- Development of Medical Devices Module on PSWOctober 17, 2026
- Notification of Health and OTC Products as Therapeutic GoodsOctober 13, 2026
- Compliance of 2D Barcoding and Serialization (Track & Trace System) for all Manufactured and Imported Pharmaceutical Products w.e.f. 9th October, 2026October 8, 2026
- Draft Guidance on Quality Control of Sterile Single-Use Syringes (For Comments)October 7, 2026
- DRAP Track & Trace System: Batch Serialization Step-by-Step Video TutorialOctober 6, 2026
- Draft guidelines for establishment of Pharmaceutical unit and Post license variationsOctober 2, 2026
- S.R.O. 1660(I)/2026 (Revised DRAP Regulatory Fee for Therapeutic Goods)October 1, 2026
- Guidelines on Post License Variations (For Comments)September 30, 2026
- Establishment of Pharmaceutical Unit and Post License Changes(For Comments)September 30, 2026
- Due to maintenance work on the fiber-optic line of NTC. DRAP e-Services may remain disrupted today. We regret the inconvenience and appreciate your cooperation.September 29, 2026
- Regulatory Guidance for Local Manufacture Of Biological Products Using Imported Bulk Concentrate or Ready-To-Fill Bulk(For comments)September 29, 2026
- Training of Online Pharmaceutical Track and Trace System for Implementation Of 2-D Barcode and Serialization (For Punjab industry)September 29, 2026
- Important Announcement – Temporary Suspension of Fee Challan ModuleSeptember 29, 2026
- Purchase of Equipments / Instruments for National Control Laboratory For Biological (NCLB) For Fy 2026-27September 25, 2026
- Supply of Chemicals, Reagents, Glassware and Reference Standards Etc. for NCLB During Fy 2026-27September 25, 2026
- Minutes of the 319th Meeting of the Central Licensing BoardSeptember 22, 2026
- Training of Online Pharmaceutical Track And Trace System for Implementation Of 2-D Barcode and Serialization (For Sindh/Baluchistan Industry)(Date 30/Sep/2026 ,Time 10:00 AM)September 21, 2026